Saravanabavaan Suntharalingam1, Christian Mikat2, Axel Wetter2, Nika Guberina2, Ahmed Salem2, Philipp Heil2, Michael Forsting2, Kai Nassenstein2. 1. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg Essen, Hufelandstrasse 55, 45122, Essen, Germany. saravanabavaan.suntharalingam@uk-essen.de. 2. Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg Essen, Hufelandstrasse 55, 45122, Essen, Germany.
Abstract
OBJECTIVES: The aim of this study was to investigate the radiation dose and image quality of a whole-body low-dose CT (WBLDCT) using spectral shaping at 100 kV (Sn 100 kV) for the assessment of osteolytic lesions in patients with multiple myeloma. METHODS: Thirty consecutive patients were retrospectively selected, who underwent a WBLDCT on a third-generation dual-source CT (DSCT) (Sn 100 kV, ref. mAs: 130). They were matched with patients, who were examined on a second-generation DSCT with a standard low-dose protocol (100 kV, ref. mAs: 111). Objective and subjective image quality, radiation exposure as well as the frequency of osteolytic lesions were evaluated. RESULTS: All scans were of diagnostic image quality. Subjective overall image quality was significantly higher in the study group (p = 0.0003). Objective image analysis revealed that signal intensities, signal-to-noise ratio and contrast-to-noise ratio of the bony structures were equal or significantly higher in the control group. There was no significant difference in the frequency of osteolytic lesions (p = 0.259). The median effective dose of the study protocol was significantly lower (1.45 mSv vs. 5.65 mSv; p < 0.0001). CONCLUSION: WBLDCT with Sn 100 kV can obtain sufficient image quality for the depiction of osteolytic lesions while reducing the radiation dose by approximately 74%. KEY POINTS: • Spectral shaping using tin filtration is beneficial for whole-body low-dose CT • Sn 100 kV yields sufficient image quality for depiction of osteolytic lesions • Whole-body low-dose CT can be performed with a median dose of 1.5 mSv.
OBJECTIVES: The aim of this study was to investigate the radiation dose and image quality of a whole-body low-dose CT (WBLDCT) using spectral shaping at 100 kV (Sn 100 kV) for the assessment of osteolytic lesions in patients with multiple myeloma. METHODS: Thirty consecutive patients were retrospectively selected, who underwent a WBLDCT on a third-generation dual-source CT (DSCT) (Sn 100 kV, ref. mAs: 130). They were matched with patients, who were examined on a second-generation DSCT with a standard low-dose protocol (100 kV, ref. mAs: 111). Objective and subjective image quality, radiation exposure as well as the frequency of osteolytic lesions were evaluated. RESULTS: All scans were of diagnostic image quality. Subjective overall image quality was significantly higher in the study group (p = 0.0003). Objective image analysis revealed that signal intensities, signal-to-noise ratio and contrast-to-noise ratio of the bony structures were equal or significantly higher in the control group. There was no significant difference in the frequency of osteolytic lesions (p = 0.259). The median effective dose of the study protocol was significantly lower (1.45 mSv vs. 5.65 mSv; p < 0.0001). CONCLUSION: WBLDCT with Sn 100 kV can obtain sufficient image quality for the depiction of osteolytic lesions while reducing the radiation dose by approximately 74%. KEY POINTS: • Spectral shaping using tin filtration is beneficial for whole-body low-dose CT • Sn 100 kV yields sufficient image quality for depiction of osteolytic lesions • Whole-body low-dose CT can be performed with a median dose of 1.5 mSv.
Authors: Evangelos Terpos; Martina Kleber; Monika Engelhardt; Sonja Zweegman; Francesca Gay; Efstathios Kastritis; Niels W C J van de Donk; Benedetto Bruno; Orhan Sezer; Annemiek Broijl; Sara Bringhen; Meral Beksac; Alessandra Larocca; Roman Hajek; Pellegrino Musto; Hans Erik Johnsen; Fortunato Morabito; Heinz Ludwig; Michele Cavo; Hermann Einsele; Pieter Sonneveld; Meletios A Dimopoulos; Antonio Palumbo Journal: Haematologica Date: 2015-10 Impact factor: 9.941
Authors: Meletios A Dimopoulos; Jens Hillengass; Saad Usmani; Elena Zamagni; Suzanne Lentzsch; Faith E Davies; Noopur Raje; Orhan Sezer; Sonja Zweegman; Jatin Shah; Ashraf Badros; Kazuyuki Shimizu; Philippe Moreau; Chor-Sang Chim; Juan José Lahuerta; Jian Hou; Artur Jurczyszyn; Hartmut Goldschmidt; Pieter Sonneveld; Antonio Palumbo; Heinz Ludwig; Michele Cavo; Bart Barlogie; Kenneth Anderson; G David Roodman; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos Journal: J Clin Oncol Date: 2015-01-20 Impact factor: 44.544
Authors: T G Gleeson; J Moriarty; C P Shortt; J P Gleeson; P Fitzpatrick; B Byrne; J McHugh; M O'Connell; P O'Gorman; S J Eustace Journal: Skeletal Radiol Date: 2008-11-14 Impact factor: 2.199
Authors: Su Min Lee; Hye Jung Choo; Sun Joo Lee; Sung Kwan Kim; In Sook Lee; Dong Wook Kim; Jin Wook Baek; Young Jin Heo Journal: Korean J Radiol Date: 2019-03 Impact factor: 3.500
Authors: Andreas S Brendlin; Ulrich Schmid; David Plajer; Maryanna Chaika; Markus Mader; Robin Wrazidlo; Simon Männlin; Jakob Spogis; Arne Estler; Michael Esser; Jürgen Schäfer; Saif Afat; Ilias Tsiflikas Journal: Tomography Date: 2022-06-24